Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dogs can smell cancer in other dogs, study finds
Specially trained dogs were able to identify canine UC with high sensitivity and specificity.
One in four dogs will develop cancer in their lifetime.

A new study has found that dogs trained to detect cancer in humans are also able to detect bladder cancer in other dogs.

Medical Detection Dogs (MDD), a charity which trains dogs to detect human cancer, has found that three of its dogs could also be trained to detect canine urothelial carcinoma (UC) of the bladder.

UC is the most common bladder cancer in dogs and accounts for almost two per cent of all reported canine cancers.

It can be difficult to diagnose as cystocentesis, taking a urine sample with a needle, can cause the tumour to seed. A definitive diagnosis can only be made through the histopathology of a biopsy sample, which is invasive, costly and delays treatment.

Due to its similarity to other conditions, it can be misdiagnosed as an infection.

MDD has now studied whether three dogs, previously trained to detect human bladder and prostate cancer, could also detect UC in dogs in a quick, non-invasive way.

The dogs were trained to smell urine samples which had been attached to metal stands in MDD’s training room. They would then indicate a response to a cancerous sample by sitting, staring or standing.

Samples had been collected from leftovers at a specialist clinic and from healthy dogs belonging to MDD and its supporters. If a dog indicated a positive sample, or did not respond to healthy samples, they were rewarded with food and play.

The results showed that the specially trained dogs were able to identify canine UC with 90 per cent sensitivity (the rate which they identified positive samples) and 95 per cent specificity (the rate which they ignored negative samples).

The study involved collaboration with researchers from the University of Bristol and was funded by The Kennel Club Charitable Trust.

Claire Guest, who is CEO, co-founder and chief scientific officer at MDD, said: “We are delighted that they were so successful at finding the odour of bladder cancer as it is a difficult disease to diagnose using traditional methods and unpleasant and intrusive for canine patients.

“When they do get diagnosed, the disease is often advanced so there is great potential value in a new, early, cheap, rapid and non-invasive diagnostic test which could lead to opportunities for earlier intervention than is possible at present.”

The full study can be found in the journal Veterinary Oncology.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.